|
|
department of Psychiatry and Behavioral Science
Research Programs
The Department of Psychiatry is involved in collaborative, multidisciplinary research efforts throughout the Temple University School of Medicine, the University and with members of our Adjunct Faculty. Some of our projects and collaborations are discussed below.
For more information about research efforts in the Department of Psychiatry, particularly for interested residency candidates, or to discuss a patient related clinical trial, please contact: Mary F Morrison, MD, MS, Vice Chairperson for Research, Department of Psychiatry, Professor of Psychiatry, Internal Medicine and Center for Substance Abuse Research at: mary.morrison@temple.edu.
Clinical Trials
Center for NeuroHIV-AIDs and Mental Health
Center for Substance Abuse Research
Center for Survey Research
Impulsivity and Cognition program
Temple is sponsoring a study of an investigational antidepressant for patients with major depressive disorder who have had an inadequate response to at least three antidepressant treatments (including current treatment). While receiving this treatment patients will still continue their current antidepressant medication. The trial is sponsored by AstraZeneca.
For more information regarding this study please contact Dr. Mary Morrison at 215-707-8688 or mary.morrison@tuhs.temple.edu. To refer patients to the study, please have them contact the research coordinator, Jen, at: 215-707-8204. More study information is available at: http://clinicaltrials.gov/ ClinicalTrials.gov Identifier: NCT01482221
Return to top
| Comprehensive NeuroAIDS Center (CNAC) |
This is a NIH- funded multidisciplinary preclinical and clinical research center that will focus on improving the diagnosis and treatment of neuropsychiatric disorders associated with HIV infection. Dr. Kamel Khalili, Chairperson of the Department of Neuroscience at Temple University, is the Director of the Center.
http://www.temple.edu/medicine/cnac
Clinical and Behavioral Core
The CORE supports translational studies and cross-disciplinary investigations in epidemiology, behavioral health, clinical trials, and public health. The Core will expand its longitudinal database from the existing clinical cohorts to include neuropsychiatric and neurocognitive assessment of a large well-characterized urban minority patient population. The core will assist in the development, design, and performance of studies that will transition basic research to the bedside and at the same time foster the transition of clinical observations and hypotheses to the laboratory. This Core will further interact with the International HIV Medicine and Research Core to provide training in advanced HIV care and neurocognitive assessment that can be used at the international site to both improve the quality of patient care and also to perform meaningful neurocognitive assessment that will benefit patients as well as the research community.
http://develop.temple.edu/medicine/departments_centers/research/
CNAC/clinical_behavioral_core.htm
Return to top
| Center for Substance Abuse Research |
This NIH-funded research center serves to facilitate multidisciplinary research on drugs of abuse and the consequences of their use, whether abused or therapeutic. This mission encompasses understanding the effects of the drugs on various systems in the body, as well as the study of the receptors to which the drugs bind, the signal transduction pathways they evoke, alterations that they induce in gene expression, neuronal pathways that they stimulate, and behaviors that they induce. Dr. Ellen Unterwald, Professor of Pharmacology, is the Director of the Center.
Research on substance abuse is particularly important to the Department because a significant proportion of the patients treated by us have problems with drug abuse. Substance abuse is an important contributing factor to other psychiatric disorders. The course of psychiatric illness can be affected by co-existing substance abuse, which can also impede effective treatment. A better understanding of the social, psychological and biological factors influencing vulnerability to and treatment of substance abuse will relieve disease burden and improve outcomes for many of our patients.
http://www.temple.edu/medicine/csar
Return to top
| Temple University Institute for Survey Research |
Founded in 1967, Temple University Institute for Survey Research (ISR) is one of the oldest and most prestigious academic survey research centers in the U.S., with more than 40 years of experience conducting national, state, and local surveys, statistical research, focus group research, needs assessments, and program evaluations. The ISR is one of only three academic survey research centers in the U.S. with the historical experience of implementing national computer- assisted in-person surveys. ISR occupies 12,000 feet of newly renovated space in the ECEC building on Cecil B. Moore Avenue that includes a 35-seat call center.
For assistance with face-to-face, telephone frame, or web surveys contact Managing Director, Heidi E. Grunwald at 215-204-2217.
Return to top
| Impulsivity and Cognition Program |
The goal of this research program is to develop new computerized methods for measuring impulsive behavior and cognitive functioning. We believe that computerization can make cognitive assessments more widely available to our patient population, allowing earlier and more widespread detection of problems, and helping us identify which patients may be vulnerable to treatment failure or relapse due to poor impulse control of cognition. Dr. John Evenden, Adjunct Professor of Psychiatry, is the Director of this program and CEO of WiltonLogic.
Dr. Evenden and other members of the Department are collaborating with researchers in the Temple University Department of Psychology, the School of Pharmacy, as well as Fox Chase Cancer Center to examine the behavior and cognitive functioning of both healthy volunteers, as well as patients who have illnesses and experience distressing symptoms.
You can find out more about the different tests we are developing, and our ongoing studies by clicking on the link below.
http://www.wiltonlogic.com/
Return to top
|
Contact Information:
Temple University Department of Psychiatry and Behavioral Sciences
Temple Episcopal Campus
1st and 3rd Floors
100 E. Lehigh Avenue
Philadelphia, PA 19125
Appointments:
T: 215-707-8496
Department-related information:
T: 215-707-8483
Residency Program Information
Temple Episcopal Campus
Ste. 301 Medical Arts Bldg.
100 E. Lehigh Avenue
Philadelphia, PA 19125
T: 215-707-0060
Crisis Response Center
Temple Episcopal Campus
100 E. Lehigh Avenue
Philadelphia, PA 19125
T: 215-707-2577
Neuropsychological Assessment
T: 215-707-8481
Outpatient Adult Psychiatry Clinic
Temple Episcopal Campus
Ste. 105 Medical Arts Bldg. 100 E. Lehigh Avenue
Philadelphia, PA 19125
Appointments:
T: 215-707-8496
Outpatient Services for Medical Students
Natalie Gluck, MD
T: 215-707-8496
|